In myeloid cells of systemic lupus erythematosus (SLE) patients, type I interferons (IFN-I) induce H3K4me3 enrichment at promoters of IFN-stimulated genes (ISGs) via the JAK-STAT pathway 88. Here, SOAT1 is linked to systemic lupus erythematosus.